We invest in rapidly growing healthcare companies and actively partner with management teams to help them scale their business.
We create customized solutions that provide liquidity and align shareholders. Building an enduring business takes time, and we recognize that not all stakeholders have the same time horizon. Our flexible, long-term approach allows us to address the issues faced by a wide range of counterparties.
Our typical investment size is $5 to $50 million. We have participated in deals as large as $1 billion.
Revelation Partners has been an ongoing strategic partner, providing liquidity to existing shareholders as well as growth capital:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“This latest round of financing, at an increased valuation, signals unwavering support from our investors while providing the company the runway needed to achieve our goal of being the world’s leading provider of remote patient monitoring solutions.”
– Peter Van Haur, CEO of VitalConnect
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“Iris is a nationally recognized leader in the telepsychiatry space. We are excited to partner with Tarik, Andy, and the rest of the exceptional management team.”
– Fred Lee, Partner
Revelation Partners has been an ongoing strategic capital partner for Metabolon:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“We are very excited to support the leader in Metabolomics services as they make this technology the standard for multi-omics analysis. They have assembled an excellent team, with CEO Rohan Hastie and CFO Gerry Haines, who are changing this field and making Metabolon the standard for this work.”
– Doug Fisher, Partner
We pride ourselves in responsiveness, problem-solving, and delivering results.
When we make an investment, we’re dedicated to being an ongoing strategic partner to help navigate growth and align shareholders.
We invest in late-stage, private companies across healthcare sectors, including medical devices, biopharmaceuticals, healthcare technology and services, and life science tools and diagnostics. If commercial scale, companies typically have at least $20 million of revenue. When value is driven by clinical progress, companies will have a validated technology.
We can acquire all classes of shares. Depending on the dynamics of the transaction, we can also acquire limited partnership interests, partner with the GP, or indirectly acquire an interest through a structured transaction.
We have a long history of transacting with a wide range of counterparties, from companies raising growth capital, to founders, venture and private equity funds, corporate investors, early employees, and angel investors seeking liquidity.
Revelation Partners creates customized solutions which provide liquidity and align shareholders of privately-held healthcare companies. Building an enduring business takes time, and not all investors – or founders – have the same time horizon.
We provide liquidity for both common and preferred classes of shares and transact with a wide range of counterparties.
Our typical investment size is $5 to $50 million. We have participated in deals as large as $1 billion.
The transaction delivered a comprehensive solution:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“This decision was made with [the companies’] growth in mind, given Revelation Partners’ expertise. We look forward to watching these companies continue to grow and flourish.”
– David Mayhew, Chief Investment Officer of GE Ventures
Revelation Partners has been an ongoing strategic partner, providing liquidity to existing shareholders as well as growth capital:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“This latest round of financing, at an increased valuation, signals unwavering support from our investors while providing the company the runway needed to achieve our goal of being the world’s leading provider of remote patient monitoring solutions.”
– Peter Van Haur, CEO of VitalConnect
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“Iris is a nationally recognized leader in the telepsychiatry space. We are excited to partner with Tarik, Andy, and the rest of the exceptional management team.”
– Fred Lee, Partner
Revelation Partners has been an ongoing strategic capital partner for Metabolon:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“We are very excited to support the leader in Metabolomics services as they make this technology the standard for multi-omics analysis. They have assembled an excellent team, with CEO Rohan Hastie and CFO Gerry Haines, who are changing this field and making Metabolon the standard for this work.”
– Doug Fisher, Partner
We pride ourselves in responsiveness, problem-solving, and delivering results.
When we make an investment, we’re dedicated to being an ongoing strategic partner to help navigate growth and align shareholders.
We invest in late-stage, private companies across healthcare sectors, including medical devices, biopharmaceuticals, healthcare technology and services, and life science tools and diagnostics. If commercial scale, companies typically have at least $20 million of revenue. When value is driven by clinical progress, companies will have a validated technology.
We can acquire all classes of shares. Depending on the dynamics of the transaction, we can also acquire limited partnership interests, partner with the GP, or indirectly acquire an interest through a structured transaction.
We have a long history of transacting with a wide range of counterparties, from companies raising growth capital, to founders, venture and private equity funds, corporate investors, early employees, and angel investors seeking liquidity.
Revelation Partners creates customized solutions which provide liquidity and align shareholders of privately-held healthcare companies. Building an enduring business takes time, and not all investors – or founders – have the same time horizon.
Fund managers often find themselves facing limited capital reserves, fund end-of-life issues, and demands for liquidity from their limited partners.
Our typical investment size is $5 to $50 million. We have participated in deals as large as $1 billion.
The transaction delivered a comprehensive solution:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“This decision was made with [the companies’] growth in mind, given Revelation Partners’ expertise. We look forward to watching these companies continue to grow and flourish.”
– David Mayhew, Chief Investment Officer of GE Ventures
Revelation Partners has been an ongoing strategic partner, providing liquidity to existing shareholders as well as growth capital:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“This latest round of financing, at an increased valuation, signals unwavering support from our investors while providing the company the runway needed to achieve our goal of being the world’s leading provider of remote patient monitoring solutions.”
– Peter Van Haur, CEO of VitalConnect
Revelation Partners has been an ongoing strategic capital partner for Metabolon:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“We are very excited to support the leader in Metabolomics services as they make this technology the standard for multi-omics analysis. They have assembled an excellent team, with CEO Rohan Hastie and CFO Gerry Haines, who are changing this field and making Metabolon the standard for this work.”
– Doug Fisher, Partner
We pride ourselves in responsiveness, problem-solving, and delivering results.
When we make an investment, we’re dedicated to being an ongoing strategic partner to help navigate growth and align shareholders.
We invest in late-stage, private companies across healthcare sectors, including medical devices, biopharmaceuticals, healthcare technology and services, and life science tools and diagnostics. If commercial scale, companies typically have at least $20 million of revenue. When value is driven by clinical progress, companies will have a validated technology.
We can acquire all classes of shares. Depending on the dynamics of the transaction, we can also acquire limited partnership interests, partner with the GP, or indirectly acquire an interest through a structured transaction.
We have a long history of transacting with a wide range of counterparties, from companies raising growth capital, to founders, venture and private equity funds, corporate investors, early employees, and angel investors seeking liquidity.
This website uses cookies to collect information in connection with your use of this website. By continuing to use this website, you agree to the use of all our cookies, which includes new versus returning visitors and country location only. We do not collect personal information. Privacy Notice & Terms and Conditions